DIAZEPAM METABOLISM BY RAT AND HUMAN LIVER INVITRO - INHIBITION BY MEPHENYTOIN

被引:19
作者
BEISCHLAG, TV
KALOW, W
MAHON, WA
INABA, T
机构
[1] Department of Pharmacology, University of Toronto
基金
英国医学研究理事会;
关键词
D O I
10.3109/00498259209053119
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Diazepam metabolism and its association with mephenytoin hydroxylase were studied in vitro using human and rat livers. 2. Enzyme kinetic parameters were obtained for the formation of p-hydroxydiazepam (p-hydroxy-DZP), N-desmethyldiazepam (NDZ), and temazepam (TMZ) from diazepam (DZP) in rat liver fractions. The K(m) values for formation in rat of p-hydroxy-DZP, NDZ and TMZ were 14+/-3 (SEM)mu-M, 44+/-4 and 63+/-8, respectively; clearance values calculated from V(max)/K(m) were 5.7, 3.2 and 4.9 ml/g per min, respectively. 3. Mephenytoin (MP) competitively inhibited, in rat liver, the formation of NDZ, but not the formation of p-hydroxy-DZP or TMZ; in human liver neither NDZ nor TMZ formation was inhibited by MP. 4. In seven different human livers the formation of p-hydroxy-DZP represented a minor pathway compared to the formation of NDZ and TMZ.
引用
收藏
页码:559 / 567
页数:9
相关论文
共 50 条
  • [31] INHIBITION OF KETAMINE METABOLISM BY DIAZEPAM
    BORONDY, PE
    GLAZKO, AJ
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 938 - 938
  • [32] Inhibition of metabolism of mephenytoin enantiomers by sulfaphenazole and fluconazole.
    Adedovin, A
    Bolcato, CB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 165 - 165
  • [33] INVITRO INHIBITION OF PROTEIN-SYNTHESIS IN RAT-LIVER AS A CONSEQUENCE OF ETHANOL-METABOLISM
    PERIN, A
    SCALABRINO, G
    SESSA, A
    ARNABOLDI, A
    BIOCHIMICA ET BIOPHYSICA ACTA, 1974, 366 (01) : 101 - 108
  • [34] CHARACTERIZATION AND INHIBITION OF MEPHENYTOIN 4-HYDROXYLASE ACTIVITY IN HUMAN-LIVER MICROSOMES
    HALL, SD
    GUENGERICH, FP
    BRANCH, RA
    WILKINSON, GR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 240 (01) : 216 - 222
  • [35] METABOLISM OF LIDOCAINE IN HUMAN-LIVER INVITRO
    HERMANSSON, J
    GLAUMANN, H
    KARLEN, B
    VONBAHR, C
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1980, 47 (01): : 49 - 52
  • [36] METABOLISM OF DIAZEPAM AND RELATED BENZODIAZEPINES BY HUMAN LIVER-MICROSOMES
    HOOPER, WD
    WATT, JA
    MCKINNON, GE
    REILLY, PEB
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1992, 17 (01) : 51 - 59
  • [37] METABOLISM OF KETAMINE INVITRO BY RAT-LIVER MICROSOMES
    ADAMS, JD
    BAILLIE, TA
    TREVOR, AJ
    CASTAGNOLI, N
    TOXICOLOGY LETTERS, 1980, : 167 - 167
  • [38] INHIBITION OF DRUG-METABOLIZING ENZYMES BY DIAZEPAM IN RAT-LIVER
    VORNE, M
    IDANPAANHEIKKILA, J
    EXPERIENTIA, 1975, 31 (08): : 962 - 963
  • [39] INVITRO METABOLISM OF LIDOFLAZINE BY RAT AND DOG LIVER FRACTIONS
    MEULDERMANS, W
    LAUWERS, W
    KNAEPS, A
    HEYKANTS, J
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1977, 27-1 (04): : 828 - 832
  • [40] THE PURINE METABOLISM OF RAT LIVER AND KIDNEY SLICES INVITRO
    BERNHEIM, F
    BERNHEIM, MLC
    ARCHIVES OF BIOCHEMISTRY, 1947, 12 (02): : 249 - 255